Treatment to target study: Insulin glargine vs NPH insulin added to oral therapy of type 2 diabetes. Successful control with less nocturnal hypoglycemia

被引：0

|

作者：

Riddle, MC

Rosenstock, J

机构：

来源：

DIABETES | 2002年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

457

引用

收藏

页码：A113 / A113

页数：1

相关论文

共 50 条

[1] Treatment to target in Type 2 diabetes: successful glycaemic control with less nocturnal hypoglycaemia with insulin glargine versus NPH insulin added to oral therapy
Riddle, M
Rosenstock, J
[J]. DIABETOLOGIA, 2002, 45 : A52 - A52
[2] Less symptomatic hypoglycemia with insulin glargine compared to NPH in patients with type 2 diabetes.
Fonseca, V
Bell, D
Mecca, T
[J]. DIABETOLOGIA, 2001, 44 : A207 - A207
[3] Economic impact of nocturnal hypoglycemia associated with the treatment of type 2 diabetes with insulin glargine or NPH insulin
Rubio-Terres, Carlos
Alvarez Guisasola, Fernando
Navarro Perez, Jorge
Delgado Alvarez, Elias
Azriel Mira, Sharona
Magana, Ana
[J]. AVANCES EN DIABETOLOGIA, 2013, 29 (01): : 19 - 26
[4] Insulin glargine plus oral therapy in patients with type 2 diabetes allows flexible dosing and leads to improved metabolic control with less hypoglycemia versus NPH insulin
Busch, K
Fritsche, A
Häring, HU
Schweitzer, MA
Vesper, I
[J]. DIABETES, 2003, 52 : A443 - A443
[5] Treatment to target study: Timing and frequency of nocturnal hypoglycemia. The value of adding bedtime basal insulin glargine over NPH insulin in insulin-naive patients with Type 2 diabetes on oral agents
Rosenstock, J
Riddle, MC
[J]. DIABETES, 2002, 51 : A482 - A482
[6] Improved glycemic control and reduced nocturnal hypoglycemia in patients with type 2 diabetes with morning administration of insulin glargine compared with NPH insulin
Fritsche, A
Schweitzer, MA
Haring, H
[J]. DIABETES, 2002, 51 : A54 - A54
[7] Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 1 diabetes
Yki-Järvinen, H
Dressler, A
Ziemen, M
[J]. DIABETES CARE, 2000, 23 (08) : 1130 - 1136
[8] Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
Rosenstock, J
Dailey, G
Massi-Benedetti, M
Fritsche, A
Lin, ZN
Salzman, A
[J]. DIABETES CARE, 2005, 28 (04) : 950 - 955
[9] Less symptomatic hypoglycemia with bedtime insulin glargine (Lantus®) compared to bedtime NPH insulin in patients with type 2 diabetes
Fonseca, V
Bell, D
Mecca, T
[J]. DIABETES, 2001, 50 : A112 - A112
[10] Lower severe hypoglycemia risk: Insulin glargine versus NPH insulin in type 2 diabetes
Dailey, George
Strange, Poul
[J]. AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (01): : 25 - 30

← 1 2 3 4 5 →